However, the absence of muscle cramps from official labeling does not definitively exclude the possibility of an association, as post-marketing surveillance and real-world clinical experience sometimes reveal adverse effects not detected in controlled trial settings
This formulation works best for patients in the early stages of their protocol, typically those working through the 2.5mg and 5mg weekly doses
Some individuals notice changes after their first injection, while others require several weeks at therapeutic doses
This safety record does not constitute approval for human use but is relevant context for researchers evaluating preclinical compounds
Keep a log of readings along with associated symptoms, timing relative to semaglutide doses, and any relevant activities or dietary factors
Some people may experience more severe constipation that lasts longer